 |
|
Many men with low testosterone levels do not receive treatment
May 27, 2008The majority of men with androgen deficiency may not be receiving treatment despite having sufficient access to care, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Androgen deficiency in men means the body has lower than normal amounts of male hormones, including testosterone, according to background information in the article. Although prescriptions for testosterone therapy for aging men have increased in recent years, treatment patterns for androgen deficiency are not clearly understood in community-dwelling U.S. males.
Susan A. Hall, Ph.D., of New England Research Institutes, Watertown, Mass., and colleagues examined data collected from 1,486 Boston-area men (average age 46.4) from April 2002 to June 2005 to estimate the number of men receiving treatment for androgen deficiency, to explain how treated and untreated men varied in seeking care and to understand potential barriers to health care. Specific symptoms of androgen deficiency include low libido, erectile dysfunction and osteoporosis and less-specific symptoms include sleep disturbance, depressed mood and tiredness.
A total of 97 men met the criteria for having androgen deficiency. Eighty-six men were symptomatic and untreated, and 11 were prescribed testosterone treatment. "Men were using the following: testosterone gel (n=1), testosterone patch (n=3), testosterone cream (n=1), testosterone cypionate [an injectable form of testosterone] (n=1) or unspecified formulations of testosterone (n=5)," the authors write. "All of the unspecified forms of testosterone used were self-reported as administered in intervals defined in weeks, which suggests that these were injectable formulations."
"Men with untreated androgen deficiency were the most likely of the three groups to have low socioeconomic status, to have no health insurance and to receive primary care in an emergency department or hospital outpatient clinic," the authors write. However, all men with treated and untreated androgen deficiency were more likely to report receiving regular care than those without the condition and reported visiting their doctor more often throughout the year (with averages of 15.1 visits for those with untreated androgen deficiency, 6.7 visits for those without the condition and 12 visits for those with treated androgen deficiency).
"Under our assumptions, a large majority (87.8 percent) of 97 men in our groups with androgen deficiency were not receiving treatment despite adequate access to care," the authors conclude. "The reasons for this are unknown but could be due to unrecognized androgen deficiency or unwillingness to prescribe testosterone therapy."
JAMA and Archives Journals
A total of 97 men met the criteria for having androgen deficiency. Eighty-six men were symptomatic and untreated, and 11 were prescribed testosterone treatment. "Men were using the following: testosterone gel (n=1), testosterone patch (n=3), testosterone cream (n=1), testosterone cypionate [an injectable form of testosterone] (n=1) or unspecified formulations of testosterone (n=5)," the authors write. "All of the unspecified forms of testosterone used were self-reported as administered in intervals defined in weeks, which suggests that these were injectable formulations."
"Men with untreated androgen deficiency were the most likely of the three groups to have low socioeconomic status, to have no health insurance and to receive primary care in an emergency department or hospital outpatient clinic," the authors write. However, all men with treated and untreated androgen deficiency were more likely to report receiving regular care than those without the condition and reported visiting their doctor more often throughout the year (with averages of 15.1 visits for those with untreated androgen deficiency, 6.7 visits for those without the condition and 12 visits for those with treated androgen deficiency).
"Under our assumptions, a large majority (87.8 percent) of 97 men in our groups with androgen deficiency were not receiving treatment despite adequate access to care," the authors conclude. "The reasons for this are unknown but could be due to unrecognized androgen deficiency or unwillingness to prescribe testosterone therapy."
JAMA and Archives Journals
Androgen Current Events and Androgen News RSSViagra for women? Drug developed as antidepressant effective in treating low libido
Pooled results from three separate clinical trials of flibanserin, a drug originally created as an antidepressant, show it is effective in treating women with acquired hypoactive sexual desire disorder. These trials were the first ever to test a therapy that works at the level of the brain to enhance libido in women reporting low sexual desire.
Hormone that affects finger length key to social behavior
The hormones, called androgens, are important in the development of masculine characteristics such as aggression and strength.
Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone.
BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease
Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD).
Prostate cancer patients on hormone therapy at increased risk for various heart diseases
New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems. Some choices of therapy appear, however, to be less risky than others.
PET/CT scans may help detect recurring prostate cancer earlier
A new study published in the September issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)/computer tomography (CT) scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed.
Turning back the clock: Fasting prolongs reproductive life span
Scientific dogma has long asserted that females are born with their entire lifetime's supply of eggs, and once they're gone, they're gone.
Denosumab increases bone density, cuts fracture risk in prostate cancer survivors
Twice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer.
Study reveals a reprogrammed role for the androgen receptor
The androgen receptor - a protein ignition switch for prostate cancer cell growth and division - is a master of adaptability.
Newly Discovered Gene Fusion May Lead to Improved Prostate Cancer Diagnosis
Researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered a new gene fusion that is highly expressed in a subset of prostate cancers.
More Androgen Current Events and Androgen News Articles
 |
Androgen Disorders in Women by Theresa Cheung (Author) Androgen disorders are perhaps the most common and overlooked of female hormonal problems. Women's health writer Theresa Cheung describes how the hormone imbalance affects women both physically and emotionally, explaining how these disorders can be treated by conventional and alternative means and noting ways to prevent the problem as well. |
 |
LG Sciences Androgen Receptor Upregulator, Capsules, 90 capsules by LG Sciences Dietary supplement. This is the most amazing supplement to ever hit the bodybuilding circuit. Receptor supercharges any product that is designed to supplement testosterone, including anabolic steroids, prohormones, anti-estrogen testosterone booster and even herbal test boosters. If you have ever done a cycle of steroids, you can't live without Receptor. It cleans out your androgen receptors which become less sensitive with each cycle. Used alone, Receptor will give you better gains by boosting your response to testosterone by up to 250% (according to studies) and increasing the number of androgen receptors. Used in combination with testosterone boosters, prohormones or steroids it will boost the effect by over 250% of those products! Finally, a totally natural way to increase receptor... |
 |
Androgens and the Aging Male by B.J. Oddens (Editor), A. Vermeulen (Editor) While menopause in women is a well-established and well documented phenomenon, the andropause in men is a relatively new concept. The terms "male menopause" and "andropause" suggest that this is an abrupt phenomenon related to a sudden deprivation of sex hormones. Unlike the menopause, which has a relatively sudden onset, the andropause appears to be a gradual process. It has been hypothesized that an androgen deficiency might develop with aging. Androgens and the Aging Male explores this hypothesis. The book focuses on the gradually progressive problems related to the decline in androgens that can occur with advancement of age. It examines the debate about the extent to which an age-dependent decline in androgens leads to health problems that affect or impair the quality of life, and the... |
 |
Prostate Cancer: Prevention, Diagnosis, and Treatment Prostate cancer is the most commonly diagnosed cancer in men in the United States. Virtually every man over 40 has cancerous growths in his prostate, although most will not die of the disease. This program focuses on what is known about preventing prostate cancer, current diagnostic techniques, and the variety of treatments available. James D. Brooks, MD, is Assistant Professor of Urology at the Stanford University School of Medicine. Dr. Brooks focuses exclusively on the treatment of prostate cancer. He is an acknowledged expert in the technique of nerve-sparing radical retropubic prostatectomy and in the surgical anatomy of the pelvis, and has carried out pioneering research on the genetic changes occurring in urological cancers. He has also published extensively on scientific and... |
 |
Caring for the Surgically Menopausal Patient: A Physiological Renaissance Also With: NCI (Producer), Dr. Gloria Bachmann (Host) Caring for the Surgically Menopausal Patient is a highlights Videostat produced by Nelson Communciations, Inc. A symposium, chaired by Dr. Gloria Bachmann, covered the Pre, Peri and Post operative management issues of the surgically menopausal patient. This video cover the key highlights of the meeting. 1) Pre-Operative and Patient Evaluation 2) Hysterectomies - Maximize Patient Comfort and Minimize Cost 3) Managing Post-Operative Patients. |
 |
Androgens in Health and Disease (Contemporary Endocrinology) by Carrie Bagatell (Editor), William J. Bremner (Editor) Univ. of Washington, Seattle. Text reviews the basic science and clinical applications of androgens. Provides discussions about androgens as anabolic agents for male conception and the use and abuse of androgens by athletes. Also covers therapeutic uses in a broad range of diseases. For researchers and practitioners. DNLM: Androgens--physiology. |
 |
Nutraceutics DHEA MAX, 60 tablets by Nutraceutics Dietary Supplement. Long acting. |
|
Resistant acne may respond to hormone adjunct: helps quell excess androgen.(Women's Health): An article from: Family Practice News by Kerri Wachter (Author) This digital document is an article from Family Practice News, published by International Medical News Group on May 15, 2004. The length of the article is 868 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Resistant acne may respond to hormone adjunct: helps quell excess androgen.(Women's Health) Author: Kerri Wachter Publication: Family Practice News (Magazine/Journal) Date: May 15, 2004 Publisher: International Medical News Group Volume: 34 Issue: 10 Page: 40(1) Distributed by Thomson... | |
 |
Primaforce Carb Slam, 5.95-Pound Tub by Primaforce Dietary supplement. Carb Slam features a long-chain, complex, super-high molecular weight, sugar-free carbohydrate from Waxy Maize Starch. Carb Slam passes through the stomach much faster than any other carbohydrate source and in the process, delivers nutrients and protein to your muscles at lightning-fast speed! In fact, Carb Slam has a molecular weight greater than maltodextrin and dextrose thus has the ability to move through the stomach faster than dextrose or maltodextrin! This Rapid Absorption and Uptake Can Help You: Deliver post-workout nutrients faster than ever before - meaning faster recovery; Produce a natural surge of post-workout insulin, the most anabolic hormone; Support extraordinary muscle fullness! (These statements have not been evaluated by the Food and Drug... |
 |
Androgen Excess Disorders in Women (Contemporary Endocrinology) by Ricardo Azziz (Editor) This thoroughly revised and comprehensive edition of a highly praised classic, Androgen Excess Disorders in Women covers the growing importance of polycystic ovary syndrome (PCOS) as the most prevalent androgen excess disorder in women. This volume addresses the latest research findings on the etiology, pathophysiology, clinical manifestations, genetics, and consequences of androgen excess disorders in women, including PCOS, nonclassic adrenal hyperplasia, androgen-secreting tumors, severe insulin-resistant hyperandrogenic syndromes, and rarer causes of androgen excess and hirsutism. Full consideration is given to the long-term consequences of androgen excess and PCOS, including endometrial hyperplasia and carcinoma, infertility, cardiovascular and lipoprotein abnormalities,... |
| © 2009 BrightSurf.com |